Texacromil
Alternative Names: CM 57201Latest Information Update: 10 Oct 1994
At a glance
- Originator Sanofi-Synthelabo
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 10 Oct 1994 No-Development-Reported for Asthma in Denmark (PO)
- 10 Oct 1994 No-Development-Reported for Asthma in France (PO)
- 10 Oct 1994 No-Development-Reported for Asthma in Germany (PO)